What Does the Food and Drug Administration Safety and Innovation Act Mean For You?
OCULAR SURFACE (2013)
期刊
OCULAR SURFACE
卷 11, 期 3, 页码 206-209出版社
ELSEVIER SCIENCE BV
关键词
作者
我是这篇论文的作者
推荐
Effect of the FDA Safety and Innovation Act on racial and gender diversity in neurosurgical device trials
Neha Siddiqui, Ryan G. Chiu, Ravi S. Nunna, Georgia Glastris, Ankit Mehta
JOURNAL OF NEUROSURGERY (2022)
Do You Know What You Eat? Kebab Adulteration in Poland
Artur Szylak, Wiktoria Kostrzewa, Jacek Bania, Aleksandra Tabis
FOODS (2023)
You Are What You Eat horizontal ellipsis But Do You Eat What You Are? The Role of Identity in Eating Behaviors-A Scoping Review
Suzannah Gerber, Sara C. Folta
NUTRIENTS (2022)
You Are What You Eat: Application of Metabolomics Approaches to Advance Nutrition Research
Abdul-Hamid M. Emwas, Nahla Al-Rifai, Kacper Szczepski, Shuruq Alsuhaymi, Saleh Rayyan, Hanan Almahasheer, Mariusz Jaremko, Lorraine Brennan, Joanna Izabela Lachowicz
FOODS (2021)
What do you mean by learning lab?
Eric Sanchez, Elsa Paukovics, Lilia Cheniti-Belcadhi, Ghada El Khayat, Bilal Said, Ouajdi Korbaa
EDUCATION AND INFORMATION TECHNOLOGIES (2022)
Impact of irrigation water type and sampling frequency on Microbial Water Quality Profiles required for compliance with US Food Safety Modernization Act Produce Safety Rule standards
Megan E. Gerdes, Raul Cruz-Cano, Sultana Solaiman, Samantha Ammons, Sarah M. Allard, Amy R. Sapkota, Shirley A. Micallef, Rachel E. Rosenberg Goldstein
ENVIRONMENTAL RESEARCH (2022)
Safety analysis of pemigatinib leveraging the US Food and Drug administration adverse event reporting system
Ying Zhang, Li Ran, Yongchao Liang, Yanqiu Zhang, Zhuoling An
FRONTIERS IN PHARMACOLOGY (2023)
Outpatient Fluoroquinolone Prescription Fills in the United States, 2014 to 2020: Assessing the Impact of Food and Drug Administration Safety Warnings
Deanna J. Buehrle, Marilyn M. Wagener, Cornelius J. Clancy
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
You see what you eat: effects of spicy food on emotion perception
Dongfang Chen, Siwei Zhang, Qi Wu, Menghao Ren
CURRENT PSYCHOLOGY (2023)
What Does Not Kill You Makes You Stronger: Supply Chain Resilience and Corporate Sustainability Through Emerging IT Capability
Zhaojun Yang, Xiaoting Guo, Jun Sun, Yali Zhang, Ying Wang
IEEE TRANSACTIONS ON ENGINEERING MANAGEMENT (2022)
Over-the-Counter Monograph Safety, Innovation, and Reform Act
Jason Gardiner, Aaron S. Kesselheim
JOURNAL OF LAW MEDICINE & ETHICS (2021)
Does cultural distance energize employees? The moderating role of psychological safety
Yingjie Yuan
PLOS ONE (2021)
What does not kill you makes you stronger: Entrepreneurs' childhood adversity, resilience, and career success
Wei Yu, Fei Zhu, Maw Der Foo, Johan Wiklund
JOURNAL OF BUSINESS RESEARCH (2022)
Tell Me What You Waste and I'll Tell You Who You Are: An Eight-Country Comparison of Consumers' Food Waste Habits
Elisa Iori, Matteo Masotti, Luca Falasconi, Enzo Risso, Andrea Segre, Matteo Vittuari
SUSTAINABILITY (2023)
What Is Safe and How Much Does It Matter? Food Vendors' and Consumers' Views on Food Safety in Urban Nigeria
Stella Nordhagen, James Lee, Nwando Onuigbo-Chatta, Augustine Okoruwa, Eva Monterrosa, Elisabetta Lambertini, Gretel H. Pelto
FOODS (2022)
Eyes on New Product Development
Gary D. Novack
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
Eyes on New Product Development
Gary D. Novack
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
Eyes on New Product Development
Gary D. Novack
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
Orphan drugs
Andrea Messori, Francesco Attanasio, Sabrina Trippoli, Roberto Banfi
LANCET (2019)
Re: Rosenfeld et al.: Lessons from recent phase III trial failures: don't design phase III trials based on retrospective subgroup analyses from phase II trials (Ophthalmology. 2018;125:1488-1491)
Gary D. Novack
OPHTHALMOLOGY (2019)
Retinal Detachment: Patient Perspective and Electronic Health Records
Gary D. Novack, Michele C. Lim
AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)
Eyes on New Product Development
Gary D. Novack
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
Eyes on New Product Development
Gary D. Novack
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
One More Time: Generic Solutions are the Same as Branded
Gary D. Novack
OPHTHALMOLOGY GLAUCOMA (2023)
US Regulatory Approval of a Drug-Eluting Contact Lens
Gary D. D. Novack
EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE (2023)
Two Randomized, Double-masked, Placebo-controlled Studies of the Local Anesthetic Effect of Articaine Ophthalmic Solution
Victor H. Gonzalez, David L. Wirta, Martin Uram, Audrey Schupp, Michelle Widmann, Gary Novack
CLINICAL OPHTHALMOLOGY (2023)
Phase I/II, Double-Masked, Randomized, Vehicle-Controlled Study of H-1337 Ophthalmic Solution for Glaucoma and Ocular Hypertension
Paul J. Hartman, David L. Cooke, Henry H. Hsu, Jeanette Stewart, Kengo Sumi, Yoko Yoshida, Hiroyoshi Hidaka, Gary D. Novack
OPHTHALMOLOGY GLAUCOMA (2023)
Efficacy and safety of netarsudil 0.02% ophthalmic solution in patients with open-angle glaucoma and ocular hypertension
Jefferson D. Berryman, Gary D. Novack
EXPERT REVIEW OF OPHTHALMOLOGY (2019)